Science Explorer Back to mapMap
Discussion
Researcher · Lentigen Technology (United States) · United States

Rimas J. Orentas

Rimas J. Orentas publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as CAR-T cell therapy research, Virus-based gene therapy research and Immune Cell Function and Interaction.

ORCID 0000-0002-6310-3467 OpenAlex
World rank
#237,140
of 7,710,434 ranked researchers
Rank in United States
#87,410
of 1,627,098
Works
290
Citations
15k
Citations per work
51.5
h-index
47
i10-index 94Top 4.3% in Oncology
Rimas J. Orentas

What does Rimas J. Orentas research?

Rimas J. Orentas's work is mostly in Medicine (41%), Immunology and Microbiology (21%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 119 works · 41.1% of their workMedicine: 119 works · 41.1% of their workOncology: 94 works · 32.4% of their workNeurology: 16 works · 5.4% of their workRadiology, Nuclear Medicine and Imaging: 10 works · 3.3% of their workLife Sciences: 107 works · 36.8% of their workImmunology and Microbiology: 61 works · 21.1% of their workImmunology: 61 works · 21.1% of their workBiochemistry, Genetics and Molecular Biology: 46 works · 15.7% of their workMolecular Biology: 27 works · 9.2% of their workGenetics: 19 works · 6.5% of their workEverything else: 64 works · 22.1% of their workTHEIR WORKRimas J. Orentas290works
Life Sciences37%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine11941.1%
    1. Immunology and Microbiology6121.1%
    2. Biochemistry, Genetics and Molecular Biology4615.7%
  3. Everything else6422.1%
  1. 1Oncology32% of their works
  2. 2Immunology21% of their works
  3. 3Molecular Biology9% of their works
  4. 4Genetics6% of their works
  5. 5Neurology5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Rimas J. Orentas's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Glycosylation, Gene Therapy, Viral Vectors and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Immunotherapy2102 topics
  2. Immunotherapy2042 topics
  3. CAR T Cells1711 topic
  4. Chimeric Antigen Receptor1711 topic
  5. Glycosylation442 topics
  6. Gene Therapy401 topic
  7. Viral Vectors401 topic
  8. Dendritic Cells391 topic
  9. Immunity391 topic
  10. NK Cell Recognition391 topic
  11. Natural Killer Cells391 topic
  12. ALK331 topic
  13. Neuroblastoma331 topic
  14. Mammalian Cells241 topic
  15. Recombinant Protein241 topic
  16. Fc Receptors201 topic
  17. Therapeutic Antibodies201 topic
  18. Acute Lymphoblastic Leukemia181 topic
  19. Childhood Cancer181 topic

Where does Rimas J. Orentas work?

Rimas J. Orentas's main affiliation in the publication record is Lentigen Technology (United States), United States.

How many publications and citations does Rimas J. Orentas have?

OpenAlex counts 290 works and 14,936 citations for Rimas J. Orentas, an h-index of 47, ranking #237,140 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Rimas J. Orentas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.